Trials / Completed
CompletedNCT04472663
Participant Reported Outcomes and Treatment Experiences in Kidney Cancer
Patient Reported Outcomes And Treatment Experiences In Renal Cell Carcinoma (ONE-RCC)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study is to collect contemporary real-world treatment patterns, clinical outcomes, humanistic burden (including patient-reported disease-specific Health-related Quality of Life (HRQoL), and treatment- related adverse events (AEs) or adverse reactions (ARs) among Advanced Renal Cell Carcinoma (aRCC) patients initiating first-line systemic therapy.
Conditions
Timeline
- Start date
- 2020-07-06
- Primary completion
- 2020-12-09
- Completion
- 2020-12-09
- First posted
- 2020-07-15
- Last updated
- 2022-04-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04472663. Inclusion in this directory is not an endorsement.